BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38343115)

  • 21. Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo.
    Sahu P; Jain VK; Aggarwal K; Kaur S; Dayal S
    Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):262-268. PubMed ID: 27552149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceleration of melanocyte senescence by the proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy.
    Dong BQ; Liao ZK; Le Y; Jiang S; Luo LF; Miao F; Le Poole IC; Lei TC
    Mech Ageing Dev; 2023 Apr; 211():111779. PubMed ID: 36731753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced Elastin Fibers and Melanocyte Loss in Vitiliginous Skin Are Restored after Repigmentation by Phototherapy and/or Autologous Minigraft Transplantation.
    Hirobe T; Enami H
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to narrow-band UVB--vitiligo-melasma versus vitiligo: a comparative study.
    Sharma P; Pai HS; Pai GS; Kuruvila M; Kolar R
    Am J Clin Dermatol; 2011 Apr; 12(2):127-32. PubMed ID: 21348543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.
    Farag AGA; Hammam MA; Al-Sharaky DR; El-Boghdady GM
    An Bras Dermatol; 2019; 94(4):434-441. PubMed ID: 31644616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
    Natta R; Somsak T; Wisuttida T; Laor L
    J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratinocytes control the proliferation and differentiation of cultured epidermal melanocytes from ultraviolet radiation B-induced pigmented spots in the dorsal skin of hairless mice.
    Hirobe T; Furuya R; Akiu S; Ifuku O; Fukuda M
    Pigment Cell Res; 2002 Oct; 15(5):391-9. PubMed ID: 12213097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients.
    Percivalle S; Piccino R; Caccialanza M; Forti S
    G Ital Dermatol Venereol; 2008 Feb; 143(1):9-14. PubMed ID: 18833047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the effect of combined intralesional injection of prostaglandin F2α with narrow band UVB phototherapy in treatment of resistant cases of vitiligo.
    Eldelee SA; Gheida SF; Sarhan NI; Ibrahim ZA; Elfar NN
    J Dermatolog Treat; 2021 Jun; 32(4):383-390. PubMed ID: 31437059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
    Verhaeghe E; Lodewick E; van Geel N; Lambert J
    Dermatology; 2011; 223(4):343-8. PubMed ID: 22269666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes.
    Wu CS; Yu CL; Wu CS; Lan CC; Yu HS
    Exp Dermatol; 2004 Dec; 13(12):755-63. PubMed ID: 15560759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Ultraviolet Light on Vitiligo.
    Singh RK
    Adv Exp Med Biol; 2017; 996():55-60. PubMed ID: 29124690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo.
    Yu S; Lan CE; Yu HS
    Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment.
    Su M; Yi H; He X; Luo L; Jiang S; Shi Y
    Exp Cell Res; 2019 Nov; 384(1):111615. PubMed ID: 31499059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous epidermal cultures and narrow-band ultraviolet B in the surgical treatment of vitiligo.
    Pianigiani E; Risulo M; Andreassi A; Taddeucci P; Ierardi F; Andreassi L
    Dermatol Surg; 2005 Feb; 31(2):155-9. PubMed ID: 15762206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrathin split-thickness skin grafting followed by narrowband UVB therapy for stable vitiligo: an effective and cosmetically satisfying treatment option.
    Majid I; Imran S
    Indian J Dermatol Venereol Leprol; 2012; 78(2):159-64. PubMed ID: 22421646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.